Clinical and Translational Oncology

, Volume 10, Issue 12, pp 847–849 | Cite as

Ewing’s sarcoma of the fibula presenting with venous thrombosis

  • Ilker Tasci
  • Gokhan Erdem
  • Teoman Dogru
  • Alper Sonmez
  • Bahtiyar Demiralp
  • Bulent Kurt
Case Reports


Malignancies account for about 20% of incidentally diagnosed venous thromboembolism. Surgery- or chemotherapy-induced risk of thrombosis is also high in patients with cancer. We report on a young male with skeletal Ewing’s sarcoma who presented with deep vein thrombosis in the affected limb, which is quite a rare clinical condition. Venous thrombosis of the lower extremities in young patients should prompt the clinician to search for underlying local malignancies.


Ewing’s sarcoma Deep vein thrombosis Factor V Leiden Fibula 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Heit JA, O’Fallon WM, Petterson TM et al (2002) Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 162:1245–1248PubMedCrossRefGoogle Scholar
  2. 2.
    Prandoni P, Falanga A, Piccioli A (2005) Cancer and venous thromboembolism. Lancet Oncol 6:401–410PubMedCrossRefGoogle Scholar
  3. 3.
    Sutherland DE, Weitz IC, Liebman HA (2003) Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment. Am J Hematol 72:43–52PubMedCrossRefGoogle Scholar
  4. 4.
    Karnes RJ, Gettman MT, Anderson PM et al (2000) Primitive neuroectodermal tumor (extraskeletal Ewing’s sarcoma) of the kidney with vena caval tumor thrombus. J Urol 164: 772PubMedCrossRefGoogle Scholar
  5. 5.
    Girot V, Johann M, Sahyoun A et al (2002) Primitive Ewing sarcoma presenting as a left adrenal mass associated with a vena cava thrombus. Prog Urol 12:668–671PubMedGoogle Scholar
  6. 6.
    Osanai T, Tsuchiya T, Ogino T (2004) Deep venous thrombosis during neoadjuvant chemotherapy in a patient with osteosarcoma: a case report. J Orthop Sci 9:182–185PubMedCrossRefGoogle Scholar
  7. 7.
    Kroegel C, Reissig A (2003) Principle mechanisms underlying venous thromboembolism: epidemiology, risk factors, pathophysiology and pathogenesis. Respiration 70:7–30PubMedCrossRefGoogle Scholar
  8. 8.
    Wells PS, Ginsberg JS, Anderson DR et al (1998) Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med 129:997–1005PubMedGoogle Scholar
  9. 9.
    Buller HR, Agnelli G, Hull RD et al (2004) Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126:401S–428SPubMedCrossRefGoogle Scholar
  10. 10.
    Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH (1995) High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 85:1504–1508PubMedGoogle Scholar
  11. 11.
    Tripodi A, Mannucci PM (2001) Laboratory investigation of thrombophilia. Clin Chem 47: 1597–1606PubMedGoogle Scholar
  12. 12.
    Didier D, Racle A, Etievent JP, Weill F (1987) Tumor thrombus of the inferior vena cava secondary to malignant abdominal neoplasms: US and CT evaluation. Radiology 162:83–89PubMedGoogle Scholar

Copyright information

© Feseo 2008

Authors and Affiliations

  • Ilker Tasci
    • 1
  • Gokhan Erdem
    • 1
  • Teoman Dogru
    • 1
  • Alper Sonmez
    • 1
  • Bahtiyar Demiralp
    • 2
  • Bulent Kurt
    • 3
  1. 1.Department of Internal MedicineGulhane School of Medicine GATA Ic Hastaliklari B.D. EtlikAnkaraTurkey
  2. 2.Department of OrthopaedyGulhane School of Medicine Etlik 06018AnkaraTurkey
  3. 3.Department of PathologyGulhane School of Medicine, EtlikAnkaraTurkey

Personalised recommendations